Goldman Sachs Innovate Equity ETF Rating → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free GINN Stock Alerts $56.76 -0.08 (-0.14%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Goldman Sachs Innovate Equity ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GINN Aggregate RatingModerate Buy2.76Holdings in GINN have an aggregate rating of Moderate Buy based on 925 analyst ratings issued in the past year covering 43 companies (34.4% of the portfolio).GINN Aggregate Price Target$61.287.96% UpsideHigh Prediction$76.46Average Prediction$61.28Low Prediction$41.75Holdings in GINN have an aggregate price target of $61.28 and a range of $41.75 to $76.46 covering 43 companies (34.4% of the portfolio).GINN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy33 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Goldman Sachs Innovate Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 43 GINN Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.66%NVDANVIDIA$924.79-2.0%5 of 5 stars2.95$966.55 4.5%42Upcoming EarningsAnalyst Forecast2.26%GOOGLAlphabet$176.06+1.1%4 of 5 stars2.89$190.60 8.3%36Analyst Revision2.10%AMZNAmazon.com$184.70+0.6%5 of 5 stars3.00$211.62 14.6%451.92%MSFTMicrosoft$420.21-0.2%5 of 5 stars2.94$454.70 8.2%34Analyst ForecastAnalyst Revision1.87%AAPLApple$189.87+0.0%5 of 5 stars2.62$204.71 7.8%34Insider Selling1.60%METAMeta Platforms$471.91-0.3%4 of 5 stars2.89$509.80 8.0%44Insider SellingAnalyst Revision1.03%LLYEli Lilly and Company$770.00-0.1%5 of 5 stars2.84$769.53 -0.1%19Analyst Revision1.03%BABAAlibaba Group$88.54+2.1%4 of 5 stars2.80$109.96 24.2%15Dividend AnnouncementOptions Volume0.86%TSLATesla$177.46+1.5%4 of 5 stars2.06$185.90 4.8%330.85%NVONovo Nordisk A/S$131.89-0.9%2 of 5 stars2.75$133.60 1.3%80.73%SESEA$73.76+3.2%1 of 5 stars2.75$72.73 -1.4%16Earnings Report0.72%AMDAdvanced Micro Devices$164.47+1.1%5 of 5 stars2.93$185.26 12.6%30Gap Up0.70%JNJJohnson & Johnson$154.64+0.2%5 of 5 stars2.46$175.86 13.7%130.70%TSMTaiwan Semiconductor Manufacturing$151.68-0.4%2 of 5 stars2.75$157.00 3.5%4Dividend Increase0.66%MAMastercard$460.27+0.3%5 of 5 stars2.96$497.78 8.2%25Analyst Revision0.66%VVisa$280.10+0.1%5 of 5 stars2.80$303.76 8.4%250.66%AVGOBroadcom$1,395.29-1.2%5 of 5 stars2.91$1,296.91 -7.1%230.65%ABBVAbbVie$166.42+1.3%5 of 5 stars2.79$176.14 5.8%14Analyst Forecast0.64%MELIMercadoLibre$1,749.17+0.6%4 of 5 stars2.92$1,820.38 4.1%120.62%WMTWalmart$64.65+1.0%4 of 5 stars2.87$67.59 4.6%31Earnings ReportAnalyst ForecastAnalyst Revision0.61%MRKMerck & Co., Inc.$131.19+0.2%5 of 5 stars2.58$131.33 0.1%12Analyst Revision0.59%ABTAbbott Laboratories$104.09-0.7%5 of 5 stars2.67$121.50 16.7%9Positive News0.59%GEGeneral Electric$159.89-0.8%4 of 5 stars2.93$174.21 9.0%140.57%INTCIntel$31.83-0.6%5 of 5 stars2.07$39.58 24.4%300.57%DISWalt Disney$103.25-0.1%5 of 5 stars2.88$126.58 22.6%250.55%GSThe Goldman Sachs Group$467.72+0.7%5 of 5 stars2.76$440.57 -5.8%21Analyst Revision0.53%SQBlock$72.26+0.7%4 of 5 stars2.76$87.59 21.2%340.53%BIDUBaidu$110.58-1.8%5 of 5 stars2.93$162.00 46.5%15Analyst Forecast0.52%QCOMQUALCOMM$193.86+0.3%5 of 5 stars2.65$180.48 -6.9%230.51%TERTeradyne$131.91+0.3%5 of 5 stars2.40$117.83 -10.7%10Analyst Revision0.51%PFEPfizer$28.64-1.0%5 of 5 stars2.40$35.86 25.2%150.49%ISRGIntuitive Surgical$398.82+0.6%5 of 5 stars2.76$396.17 -0.7%170.49%MDTMedtronic$85.92+0.3%5 of 5 stars2.40$94.91 10.5%10Upcoming Earnings0.48%TMOThermo Fisher Scientific$595.30-0.3%5 of 5 stars2.71$607.35 2.0%17Analyst RevisionPositive News0.48%VRTXVertex Pharmaceuticals$445.21+1.0%4 of 5 stars2.48$432.18 -2.9%25Analyst Upgrade0.48%COINCoinbase Global$207.60+4.2%3 of 5 stars2.35$214.67 3.4%20Analyst UpgradeGap Up0.45%AMGNAmgen$312.47-0.7%5 of 5 stars2.52$305.65 -2.2%210.44%BLKBlackRock$812.22+0.6%4 of 5 stars2.80$845.42 4.1%10Dividend Announcement0.43%SYKStryker$334.68+0.2%5 of 5 stars2.78$365.94 9.3%180.42%CSCOCisco Systems$48.17-0.4%5 of 5 stars2.24$56.47 17.2%21Earnings ReportDividend AnnouncementAnalyst Forecast0.41%KKRKKR & Co. Inc.$104.64+0.5%5 of 5 stars2.92$94.50 -9.7%130.41%REGNRegeneron Pharmaceuticals$982.29+1.5%4 of 5 stars2.76$989.36 0.7%21Insider Selling0.41%CMCSAComcast$39.27-0.3%5 of 5 stars2.52$49.33 25.6%21Dividend Announcement This page (NYSEARCA:GINN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Goldman Sachs Innovate Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
